BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
96858 results:

  • 1. A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada.
    Tan VS; Tjong MC; Chan WC; Yan M; Delibasic V; Darling G; Davis LE; Doherty M; Hallet J; Kidane B; Mahar A; Mittmann N; Parmar A; Tan H; Wright FC; Coburn NG; Louie AV
    Support Care Cancer; 2024 May; 32(6):381. PubMed ID: 38787434
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Sentinel Lymph Node Mapping in lung cancer: A Pilot Study for the Detection of Micrometastases in Stage I Non-Small Cell lung cancer.
    Romano G; Zirafa CC; Calabrò F; Alì G; Manca G; De Liperi A; Proietti A; Manfredini B; Di Stefano I; Marciano A; Davini F; Volterrani D; Melfi F
    Tomography; 2024 May; 10(5):761-772. PubMed ID: 38787018
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice.
    Edin ML; Gruzdev A; Graves JP; Lih FB; Morisseau C; Ward JM; Hammock BD; Bosio CM; Zeldin DC
    FASEB J; 2024 May; 38(10):e23692. PubMed ID: 38786655
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Upregulation of mRNA Expression of ADGRD1/GPR133 and ADGRG7/GPR128 in SARS-CoV-2-Infected lung Adenocarcinoma Calu-3 Cells.
    Žáčková S; Pávová M; Trylčová J; Chalupová J; Priss A; Lukšan O; Weber J
    Cells; 2024 May; 13(10):. PubMed ID: 38786015
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Patient and Family Financial Burden in cancer: A Focus on Differences across Four Provinces, and Reduced Spending Including Decisions to Forego Care in Canada.
    Longo CJ; Maity T; Fitch MI; Young JT
    Curr Oncol; 2024 May; 31(5):2713-2726. PubMed ID: 38785487
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. 12-Month Trajectories of Health-Related Quality of Life Following Hospitalization in German cancer Centers-A Secondary Data Analysis.
    Eichler M; Hönig K; Bergelt C; Faller H; Maatouk I; Hornemann B; Stein B; Teufel M; Goerling U; Erim Y; Geiser F; Niecke A; Senf B; Weis J
    Curr Oncol; 2024 Apr; 31(5):2376-2392. PubMed ID: 38785458
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.
    Xu Q; Li J; Yang Y; Zhuo L; Gao H; Jiang S; Li W
    Ren Fail; 2024 Dec; 46(1):2355353. PubMed ID: 38785304
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HUNCHEST projects-advancing low-dose CT lung cancer screening in Hungary.
    Kerpel-Fronius A; Bogos K
    Pathol Oncol Res; 2024; 30():1611635. PubMed ID: 38784857
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC.
    Mao Z; Pang G; Huang X; Chen X; Wu J; Xu X; Teng Z; Tan Y; Wang P
    BMC Pulm Med; 2024 May; 24(1):253. PubMed ID: 38783253
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer Treatment Before and After Physician-Pharmacy Integration.
    Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
    JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk factors for pulmonary complications after colorectal cancer surgery: a Japanese multicenter study.
    Tominaga T; Nonaka T; Takamura Y; Oishi K; Hashimoto S; Shiraishi T; Noda K; Ono R; Ishii M; Hisanaga M; Takeshita H; Fukuoka H; Oyama S; Ishimaru K; Kunizaki M; Sawai T; Matsumoto K
    Int J Colorectal Dis; 2024 May; 39(1):76. PubMed ID: 38780615
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical Variables and Radiomics Features for Predicting Pneumothorax in Patients Undergoing CT-guided Transthoracic Core Needle Biopsy.
    Huang YS; Chen JL; Ko WC; Chang YH; Chang CH; Chang YC
    Radiol Cardiothorac Imaging; 2024 Jun; 6(3):e230278. PubMed ID: 38780426
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Development and validation of a model for predicting upstage in minimally invasive lung adenocarcinoma in Chinese people.
    Liao Y; Li Z; Song L; Xue Y; Chen X; Feng G
    World J Surg Oncol; 2024 May; 22(1):135. PubMed ID: 38778366
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. 3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.
    Luo W; Chang G; Lin D; Xie H; Sun H; Li Z; Mo S; Wang R; Wang Y; Zheng Z
    PLoS One; 2024; 19(5):e0303186. PubMed ID: 38776295
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Assessment of Radiation Induced Pneumonitis and Pericarditis in Patients Undergoing Breast Conservative Treatment Using Hypofractionated Simultaneous Integrated Boost Technique.
    Sundaramoorthy S; Karunanidhi G; Pal P; C SV; Radhakrishnan H
    Gulf J Oncolog; 2024 May; 1(45):15-29. PubMed ID: 38774929
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epigastric Pain and Dysphagia in a 36-Year-Old Man Due to Primary Esophageal Small Cell Carcinoma.
    Aijaz P; Niazi MA; Chela HK; Zahid K; Daglilar E
    Am J Case Rep; 2024 May; 25():e943392. PubMed ID: 38773743
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exploring shared decision-making needs in lung cancer screening among high-risk groups and health care providers in China: a qualitative study.
    Lin X; Wang F; Li Y; Lei F; Chen W; Arbing RH; Chen WT; Huang F
    BMC Cancer; 2024 May; 24(1):613. PubMed ID: 38773461
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
    Ma H; Wu T; Zhang Q; Ding Q
    BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Interventions for smoking cessation in hospitalised patients.
    Streck JM; Rigotti NA; Livingstone-Banks J; Tindle HA; Clair C; Munafò MR; Sterling-Maisel C; Hartmann-Boyce J
    Cochrane Database Syst Rev; 2024 May; 5(5):CD001837. PubMed ID: 38770804
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer.
    Hao Y; Zhang X; Cui G; Qi X; Jiang Z; Yu L
    Cancer Med; 2024 May; 13(10):e7296. PubMed ID: 38770671
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4843.